Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the relationship between urinary prostaglandin E2 (UPGE2),
kallikrein
(UKal), graft function and complications after renal transplantation in 11 patients. Grafts of 9 patients were from living-related donors (LRD), and other 2 patients were from a cadaveric donor (CAD). UPGE2 was measured by the radio immunoassay, and UKal was measured by the amidolytic method using Pro-Phe-Arg-MCA. The results were as follows. 1. In 5 of 6 patients from LRD without acute rejection episode (ARE), both UPGE2 and UKAL were within normal and/or slightly less than normal. UKal values of the other patient were high in his donor. 2. In 2 of 3 recipients from LRD who experienced ARE, UKal increased prior to ARE. UPGE2 also increased at the time of ARE, but it showed a periodic rise in the stable condition. 3. In 1 of 2 recipients from CAD, UKal exhibited a transient elevation at the time of acute tubular necrosis (ATN) and
pyelonephritis
while UPGE2 was low. In another recipient, UKal was almost within normal range at the time of ATN, and UPGE2 showed a periodic rise. 4. A significant correlation was seen between UKal, UPGE2 and UAld in the recipients from LRD without ARE (except 1 patient who showed high UKal values). However, the correlation was blurred inclusive of values in the patients who experienced ARE or other complications. There was no relationship between UKal, UPGE2, creatinine clearance, urine volume and urinary sodium. 5. Soybean trypsin inhibitor (STI) was used for the confirmation of specificity of the amidolytic method.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[Urinary prostaglandin E2 and kallikrein-like activity excretion in renal transplant recipients]. 235 62
The activity of the
kallikrein
-kinin, prostaglandin and cyclase systems was assessed in 117 patients with chronic
pyelonephritis
with and without arterial hypertension.
Pyelonephritis
is shown to be associated with a dysfunction of the pressor-depressor mechanisms examined, featuring a depression of vasodepressor reactions. Patients with normal, increased and depressed humoral parameters could be found in each study group, the changes being particularly marked in patients with chronic
pyelonephritis
, combined with arterial hypertension.
...
PMID:[Function of the kallikrein-kinin and prostaglandin systems of the kidneys in patients with chronic pyelonephritis]. 271 90
A total of 48 patients with calculous
pyelonephritis
were examined before and after surgery. A study was made of the fibrinolytic system (according to the status of XIIa
kallikrein
-dependent fibrinolysis, lysis of the plasma clots and euglobulin lysis) and of the
kallikrein
-kinin system of the plasma (according to
kallikrein
activity, kininogen content, kininase activity, spontaneous esterase activity and prekallikrein content). The patients with calculos
pyelonephritis
demonstrated KKS activation and fibrinolysis reduction related to both the lowering of the activator levels and elevation of antiplasmin levels, which in turn created the risk of thrombophilia in this group of patients.
...
PMID:[Changes in the indicators of the fibrinolytic and kallikrein-kinin systems in patients with calculous pyelonephritis]. 656 90
Activity of the
kallikrein
-kinin system and proteinase inhibitors were studied in blood plasma of children at various stages of tubulointerstitial nephritis,
pyelonephritis
and dysmetabolic nephropathy. Similar alterations in the activities of
kallikrein
-kinin system and in the rate of proteolysis inhibition were observed in tubulointerstitial nephritis and
pyelonephritis
. Supplementary demonstrations were obtained about development of inflammation in tubulointerstitial nephritis. Absence of the
kallikrein
-kinin system activation and a decrease in the alpha 2-macroglobulin content were detected in dysmetabolic nephropathy. Definite components of the
kallikrein
-kinin system and the proteolysis inhibitors may be used as indicators in differential diagnosis of tubulointerstitial nephritis and dysmetabolic nephropathy.
...
PMID:[The kallikrein-kinin system and blood plasma proteolysis inhibitors in various childhood nephropathies]. 752 46
A total of 83 patients with chronic renal failure (CRF) at azotemia stage (S. I. Riabov's classification) complicating
pyelonephritis
were treated: 19 patients received symptomatic standard therapy (group 1), 29 patients received combined therapy with enterosorption (group 2), 35 patients received combined treatment with plasmapheresis (group 3). The efficacy of the treatments was controlled by platelet tests (platelet, coagulative hemostasis, fibrinolytic plasma activity) and parameters of
kallikrein
-kinin system. Treatment results in group 1 are characterized as poor: insignificant improvement of uremia, DIC syndrome against unchanged inhibition of
kallikrein
-kinin system. Group 2 patients achieved moderate response: uremia reduced to normal azotemia values, DIC syndrome and inhibition of
kallikrein
-kinin system reduced. Patients of group 3 got disappeared DIC syndrome and normal
kallikrein
-kinin system against high azotemia.
...
PMID:[Changes in the hemostatic system indices of patients with chronic kidney failure under the influence of enterosorption and plasmapheresis]. 798 57